A novel anti-HIV immunotherapy to cure HIV
- PMID: 28079543
- PMCID: PMC7898938
- DOI: 10.1097/QAD.0000000000001331
A novel anti-HIV immunotherapy to cure HIV
Conflict of interest statement
Conflicts of interest
There are no conflicts of interest.
Comment on
-
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).AIDS. 2017 Jan 28;31(3):321-332. doi: 10.1097/QAD.0000000000001276. AIDS. 2017. PMID: 27677160
References
-
- Stein J, Storcksdieck Genannt Bonsmann M, Streeck H. Barriers to HIV cure. HLA 2016; 88:155–163. - PubMed
-
- Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360:692–698. - PubMed
-
- Cannon PM, Kohn DB, Kiem HP. HIV eradication – from Berlin to Boston. Nat Biotechnol 2014; 32:315–316. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
